Active, Not Recruiting
Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT01880567
- Conditions
- CCND1 Positive, CCND2 Positive, CCND3 Positive, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States